P. Pyélonéphrites, Les carbapénèmes, une possibilité même en ambulatoire ?, p.69

A. Decoster, J. Lemahieu, E. Dehecq, and M. Duhamel, Available from Cours de bactériologie [Internet] Cours de microbiologie de la faculté libre de médecine de Lille Available from: http://anne.decoster.free.fr/bindex.html 3. Philippon A. Cours de bactériologie générale [Internet]. Campus de microbiologie médicale Available from: http://www.microbe-edu.org/index.html 4. Fleming A. Penicillin. Nobel Lecture Available from: http://www.nobelprize.org/nobel_prizes/medicine/laureates Available from Available from, pdf 5. InVS > Résistance aux anti-infectieux > Glossaire [Internet]. Institut de Veille Sanitaire, pp.83-93, 1945.

M. Wilson, Bacteriology of humans: an ecological perspective, p.351, 2008.

E. Costello, C. Lauber, M. Hamady, N. Fierer, J. Gordon et al., Bacterial Community Variation in Human Body Habitats Across Space and Time, Science, vol.326, issue.5960, pp.1694-1701, 2009.
DOI : 10.1126/science.1177486

J. Moller, A. Bak, A. Stenderup, H. Zachariae, and H. Afzelius, Changing Patterns of Plasmid-Mediated Drug Resistance During Tetracycline Therapy, Antimicrobial Agents and Chemotherapy, vol.11, issue.3, pp.388-91, 1977.
DOI : 10.1128/AAC.11.3.388

N. Høiby, J. Jarløv, M. Kemp, M. Tvede, J. Bangsborg et al., Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis, The Lancet, vol.349, issue.9046, pp.167-176, 1997.
DOI : 10.1016/S0140-6736(96)09229-X

W. Huber, D. Korica, T. Neal, P. Schnurrenberger, and R. Martin, Antibiotic Sensitivity Patterns and R Factors in Domestic and Wild Animals, Archives of Environmental Health: An International Journal, vol.7, issue.5, pp.561-568, 1971.
DOI : 10.1016/S0140-6736(66)91705-3

S. Levy, G. Fitzgerald, and A. Macone, Changes in Intestinal Flora of Farm Personnel after Introduction of a Tetracycline-Supplemented Feed on a Farm, New England Journal of Medicine, vol.295, issue.11, pp.583-591, 1976.
DOI : 10.1056/NEJM197609092951103

L. Armand-lefevre, R. Ruimy, and A. Andremont, Isolates from Healthy Pig Farmers, Human Controls, and Pigs, Emerging Infectious Diseases, vol.11, issue.5, p.711, 2005.
DOI : 10.3201/eid1105.040866

URL : http://doi.org/10.3201/eid1105.040866

S. Bronzwaer, A European Study on the Relationship between Antimicrobial Use and Antimicrobial Resistance, Emerging Infectious Diseases, vol.8, issue.3, pp.278-82, 2002.
DOI : 10.3201/eid0803.010192

H. Goossens, M. Ferech, V. Stichele, R. Elseviers, and M. , Outpatient antibiotic use in Europe and association with resistance: a cross-national database study, The Lancet, vol.365, issue.9459, pp.579-87, 2005.
DOI : 10.1016/S0140-6736(05)70799-6

P. Ehrlich, Address in Pathology on chemotherapeutics : scientific principles, methods, and results, Aug, vol.4694182, issue.164694, pp.445-51, 1913.

E. Abraham and E. Chain, An Enzyme from Bacteria able to Destroy Penicillin, Nature, vol.146, issue.3713, pp.837-837, 1940.
DOI : 10.1038/146837a0

Y. Michel-briand, Une histoire de la résistance aux antibiotiques : A propos de six bactéries. Paris: L'Harmattan, 2009.

M. Swann, Report of the joint committee on the use of antibiotics in animal husbandry and veterinary medicine. London: Her Majesty's Stationary Office, 1969.

M. Nicolas-chanoine and . Brève, Observatoire national de l'épidémiologie de la résistance aux antibiotiques (Onerba) en France : 15 ans d'histoire. Bull Épidémiologique Santé Anim Aliment, 2012.

V. Jarlier, C. A. Réseau, and . Bmr-raisin, Surveillance des bactéries multirésistantes dans les établissements de santé en France. Résultats 2002. Saint-Maurice: Institut de veille sanitaire, p.31, 2002.

L. Maladie, Le bon usage des antibiotiques, 2002.

. Ministère-du-travail, . Emploi, . De, and . Santé, Plan antibiotiques [Internet]. Plan antibiotiques -Moins prescrire d'antibiotiques, c'est préserver leur efficacité. Available from

S. Bronzwaer, W. Goettsch, B. Olsson-liljequist, M. Wale, A. Vatopoulos et al., Système Européen de Surveillance de la Résistance Antimicrobienne (EARSS): objectifs et organisation, Euro Surveill, vol.4, issue.4, pp.41-45, 1999.

. Plan-cadre-de-lutte-contre-la, Journée mondiale de la santé 2011: Organisation mondiale de la Santé Available from: http://www.who.int/world-health- day, Avril, 2011.

P. Astagneau, Y. Costa, P. Legrand, J. Lucet, L. Marty et al., Maîtrise de la diffusion des bactéries multirésistantes aux antibiotiques -Ministère des Affaires sociales et de la Santé -www

V. Jarlier, I. Arnaud, and H. Blanchard, Surveillance des bactéries multirésistantes dans les établissements de santé en France Réseau BMR-Raisin ? Résultats, 2011.

G. French, A. Cheng, J. Ling, P. Mo, and S. Donnan, Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence, Journal of Hospital Infection, vol.15, issue.2, pp.117-142, 1990.
DOI : 10.1016/0195-6701(90)90120-D

J. Pitout, K. Laupland, D. Church, M. Menard, and J. Johnson, Virulence Factors of Escherichia coli Isolates That Produce CTX-M-Type Extended-Spectrum ??-Lactamases, Antimicrobial Agents and Chemotherapy, vol.49, issue.11, pp.4667-70, 2005.
DOI : 10.1128/AAC.49.11.4667-4670.2005

A. Soriano, J. Martinez, J. Mensa, F. Marco, M. Almela et al., Pathogenic Significance of Methicillin Resistance for Patients with Staphylococcus aureus Bacteremia, Clinical Infectious Diseases, vol.30, issue.2, pp.368-73, 2000.
DOI : 10.1086/313650

H. Boucher, G. Talbot, D. Benjamin, J. Bradley, R. Guidos et al., 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.56, issue.12, pp.1685-94, 2013.
DOI : 10.1093/cid/cit152

L. Direction-générale-de and . Santé, Infections liées aux soins réalisés en dehors des établissements de santé -guide de prévention. Ministère de la Santé et des Solidarités, 0128.

J. Carlet, P. Collignon, D. Goldmann, H. Goossens, I. Gyssens et al., Society's failure to protect a precious resource: antibiotics, The Lancet, vol.378, issue.9788, pp.369-71, 2011.
DOI : 10.1016/S0140-6736(11)60401-7

J. Carlet, Sauvons les antibiotiques, Alliance Contre le développement des Bactéries Multi-Résistantes aux Antibiotiques, 2011.
DOI : 10.1016/j.medmal.2011.06.003

A. Therapeutics, New anti-infectives company, Allecra Therapeutics, created with ?15 million series a financing

Y. Alexandre, L. Blay, G. Boisramé-gastrin, S. , L. Gall et al., Probiotics: A new way to fight bacterial pulmonary infections? Médecine Mal Infect, 2013.

G. Reid, J. Burton, and E. Devillard, The rationale for probiotics in female urogenital healthcare, MedGenMed Medscape Gen Med, vol.6, issue.1, p.49, 2004.

A. Wright, C. Hawkins, E. Änggård, and D. Harper, ; a preliminary report of efficacy, Clinical Otolaryngology, vol.8, issue.4, pp.349-57, 2009.
DOI : 10.1111/j.1749-4486.2009.01973.x

D. Alemayehu, P. Casey, O. Mcauliffe, C. Guinane, J. Martin et al., Bacteriophages MR299-2 and NH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. mBio, pp.29-41, 2012.

R. Jepson and J. Craig, Cranberries for preventing urinary tract infections Available from, Cochrane Database of Systematic Reviews [Internet], 2008.

R. Jepson, G. Williams, and J. Craig, Cranberries for preventing urinary tract infections In: The Cochrane Collaboration Available from, Cochrane Database of Systematic Reviews [Internet], 2012.

D. Paterson and R. Bonomo, Extended-Spectrum ??-Lactamases: a Clinical Update, Clinical Microbiology Reviews, vol.18, issue.4, pp.657-86, 2005.
DOI : 10.1128/CMR.18.4.657-686.2005

D. Livermore, Defining an extended-spectrum ??-lactamase, Clinical Microbiology and Infection, vol.14, issue.s1, pp.3-10, 2008.
DOI : 10.1111/j.1469-0691.2007.01857.x

URL : http://doi.org/10.1111/j.1469-0691.2007.01857.x

M. Jones and . Conjugation, Available from: http://fr.wikipedia.org/wiki/Fichier:Conjugation.svg, 2009.

K. Bush, G. Jacoby, and A. Medeiros, A functional classification scheme for beta-lactamases and its correlation with molecular structure, Antimicrobial Agents and Chemotherapy, vol.39, issue.6, pp.1211-1244, 1995.
DOI : 10.1128/AAC.39.6.1211

K. Bush, The ABCD???s of ??-lactamase nomenclature, Journal of Infection and Chemotherapy, vol.19, issue.4, pp.549-59, 2013.
DOI : 10.1007/s10156-013-0640-7

H. Knothe, P. Shah, V. Krcmery, M. Antal, and S. Mitsuhashi, Ubertragbare Resistenz gegen??ber Cefotaxim, Cefoxitin, Cefamandol und Cefuroxim in klinischen Isolaten von Klebsiella pneumoniae und Serratia marcescens, Infection, vol.147, issue.6, pp.315-322, 1983.
DOI : 10.1007/BF01641355

D. Sirot, J. Sirot, R. Labia, A. Morand, P. Courvalin et al., : identification of CTX-1, a novel ??-lactamase, Journal of Antimicrobial Chemotherapy, vol.20, issue.3, pp.323-357, 1987.
DOI : 10.1093/jac/20.3.323

C. Brun-buisson, A. Philippon, M. Ansquer, P. Legrand, F. Montravers et al., Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. The Lancet, pp.302-308, 1987.

M. Kitzis, D. Billot-klein, F. Goldstein, R. Williamson, T. Van-nhieu et al., Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors., Antimicrobial Agents and Chemotherapy, vol.32, issue.1, pp.9-14, 1988.
DOI : 10.1128/AAC.32.1.9

A. Philippon, R. Labia, and G. Jacoby, Extended-spectrum beta-lactamases., Antimicrobial Agents and Chemotherapy, vol.33, issue.8, p.1131, 1989.
DOI : 10.1128/AAC.33.8.1131

V. Cattoir, Les nouvelles bêta-lactamases à spectre étendu (BLSE) Mises au Point en Anesthésie- Réanimation [Internet]. MAPAR éditions Available from: http://www.mapar.org/article, pp.203-212, 2008.

R. Bonnet, Growing Group of Extended-Spectrum ??-Lactamases: the CTX-M Enzymes, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, pp.1-14
DOI : 10.1128/AAC.48.1.1-14.2004

D. Livermore, R. Canton, M. Gniadkowski, P. Nordmann, G. Rossolini et al., CTX-M: changing the face of ESBLs in Europe, Journal of Antimicrobial Chemotherapy, vol.59, issue.2, pp.165-74, 2007.
DOI : 10.1093/jac/dkl483

J. Pitout and K. Laupland, Extended-spectrum ??-lactamase-producing Enterobacteriaceae: an emerging public-health concern, The Lancet Infectious Diseases, vol.8, issue.3, pp.159-66, 2008.
DOI : 10.1016/S1473-3099(08)70041-0

R. Cantón and T. Coque, The CTX-M ??-lactamase pandemic, Current Opinion in Microbiology, vol.9, issue.5, pp.466-75, 2006.
DOI : 10.1016/j.mib.2006.08.011

D. Elhani, Les bêta-lactamases à spectre étendu : le défi s'accentue, Ann Biol Clin (Paris), vol.70, issue.2, pp.117-157, 2012.

I. Arnaud, V. Jarlier, A. Carbonne-berger, S. Maugat, O. Bajolet et al., Bactéries multirésistantes (BMR) en milieu hospitalier : entérobactéries productrices de ?-lactamases à spectre étendu (EBLSE) et Staphylococcus aureus résistants à la méticilline (SARM), pp.42-43473, 2002.

H. Sénéchal, M. Eveillard, and N. Garreau, Surveillance des Bactéries Multi Résistantes. Résultats -Année 2011. CCLIN-Ouest, p.89

M. Cormican, D. Morris, G. Corbett-feeeney, and J. Flynn, Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection, Diagnostic Microbiology and Infectious Disease, vol.32, issue.4, pp.317-326, 1998.
DOI : 10.1016/S0732-8893(98)00113-8

F. Goldstein, Antibiotic Susceptibility of Bacterial Strains Isolated from Patients with Community-Acquired Urinary Tract Infections in France, European Journal of Clinical Microbiology & Infectious Diseases, vol.19, issue.2, pp.112-119, 2000.
DOI : 10.1007/s100960050440

J. Pitout, N. Hanson, D. Church, and K. Laupland, Population-Based Laboratory Surveillance for Escherichia coli-Producing Extended-Spectrum ??-Lactamases: Importance of Community Isolates with blaCTX-M Genes, Clinical Infectious Diseases, vol.38, issue.12, pp.1736-1777, 2004.
DOI : 10.1086/421094

J. Rodríguez-baño, M. Navarro, L. Romero, L. Martínez-martínez, M. Muniain et al., Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients, Journal of Clinical Microbiology, vol.42, issue.3, pp.1089-94, 2004.
DOI : 10.1128/JCM.42.3.1089-1094.2004

H. Khanfar, K. Bindayna, A. Senok, and G. Botta, Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings, J Infect Dev Ctries, vol.3, issue.04, pp.295-304, 2009.

N. Woodford, Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum ??-lactamases in the UK, Journal of Antimicrobial Chemotherapy, vol.54, issue.4, pp.735-778, 2004.
DOI : 10.1093/jac/dkh424

R. Ben-ami, M. Schwaber, S. Navon-venezia, D. Schwartz, M. Giladi et al., Influx of Extended-Spectrum ??-Lactamase--Producing Enterobacteriaceae into the Hospital, Clinical Infectious Diseases, vol.42, issue.7, pp.925-959, 2006.
DOI : 10.1086/500936

C. Moor, S. Roberts, G. Simmons, S. Briggs, A. Morris et al., Extended-spectrum ??-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand, Journal of Hospital Infection, vol.68, issue.4, pp.355-62, 2008.
DOI : 10.1016/j.jhin.2008.02.003

G. Bou, M. Cartelle, M. Tomas, D. Canle, F. Molina et al., Identification and Broad Dissemination of the CTX-M-14 ??-Lactamase in Different Escherichia coli Strains in the Northwest Area of Spain, Journal of Clinical Microbiology, vol.40, issue.11, pp.4030-4036, 2002.
DOI : 10.1128/JCM.40.11.4030-4036.2002

J. Rodríguez-baño, M. Navarro, L. Romero, M. Muniain, M. De-cueto et al., Bacteremia Due to Extended-Spectrum ??-Lactamase-Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge, Clinical Infectious Diseases, vol.43, issue.11, pp.1407-1421, 2006.
DOI : 10.1086/508877

U. Luvsansharav, I. Hirai, M. Niki, A. Nakata, A. Yoshinaga et al., Prevalence of fecal carriage of extended-spectrum ??-lactamase-producing Enterobacteriaceae among healthy adult people in Japan, Journal of Infection and Chemotherapy, vol.17, issue.5, pp.722-727, 2011.
DOI : 10.1007/s10156-011-0225-2

Y. Ko, H. Moon, M. Hur, C. Park, S. Cho et al., Fecal carriage of extended-spectrum ?lactamase-producing Enterobacteriaceae in Korean community and hospital settings, Infection, 2012.

H. Villar, M. Baserni, and M. Jugo, Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings, The Journal of Infection in Developing Countries, vol.7, issue.08, pp.630-634, 2013.
DOI : 10.3855/jidc.2900

N. Wickramasinghe, L. Xu, A. Eustace, S. Shabir, T. Saluja et al., High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK, Journal of Antimicrobial Chemotherapy, vol.67, issue.5, pp.1108-1121, 2012.
DOI : 10.1093/jac/dks018

E. Reuland, I. Overdevest, N. Naiemi, J. Kalpoe, M. Rijnsburger et al., High prevalence of ESBL-producing Enterobacteriaceae carriage in Dutch community patients with gastrointestinal complaints, Clinical Microbiology and Infection, vol.19, issue.6, pp.542-551
DOI : 10.1111/j.1469-0691.2012.03947.x

B. Sallem, R. , B. Slama, K. Estepa, V. Jouini et al., Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia, European Journal of Clinical Microbiology & Infectious Diseases, vol.46, issue.7, pp.1511-1517, 2011.
DOI : 10.1007/s10096-011-1471-z

A. Birgy, R. Cohen, C. Levy, P. Bidet, C. Courroux et al., Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceaein french children, BMC Infectious Diseases, vol.41, issue.5, p.315, 2012.
DOI : 10.1093/jac/dkl326

M. Nicolas-chanoine, C. Gruson, S. Bialek-davenet, X. Bertrand, F. Thomas-jean et al., 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum ??-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre, Journal of Antimicrobial Chemotherapy, vol.68, issue.3, pp.562-570, 2009.
DOI : 10.1093/jac/dks429

URL : https://hal.archives-ouvertes.fr/hal-00802788

R. Lepeule, R. Rakotomalala, L. Armand-lefèvre, E. Ruppe, G. Birgand et al., High rate of extended-spectrum beta-lactamases (ESBL)-producing enterobacteria and contribution of quantitative digestive carriage in patients hospitalised in an infectious diseases unit, 2013.

B. Li, Y. Zhong, X. Fu, Y. Qiu, S. Wang et al., Duration of Stool Colonization in Healthy Medical Students with Extended-Spectrum-??-Lactamase-Producing Escherichia coli, Antimicrobial Agents and Chemotherapy, vol.56, issue.8, pp.4558-4567, 2012.
DOI : 10.1128/AAC.00171-12

A. Apisarnthanarak, T. Bailey, and V. Fraser, Duration of Stool Colonization in Patients Infected with Extended?Spectrum ??Lactamase?Producing Escherichia coli and Klebsiella pneumoniae, Clin Infect Dis Apr, vol.1546, issue.8, pp.1322-1325, 2008.

G. Birgand, L. Armand-lefevre, I. Lolom, E. Ruppe, A. Andremont et al., Duration of colonization by extended-spectrum ??-lactamase-producing Enterobacteriaceae after hospital discharge, American Journal of Infection Control, vol.41, issue.5, pp.443-450, 2013.
DOI : 10.1016/j.ajic.2012.05.015

J. Tham, M. Walder, E. Melander, and I. Odenholt, Duration of colonization with extended-spectrum betalactamase-producing Escherichia coli in patients with travellers' diarrhoea, Scand J Infect Dis, 2012.

R. Alsterlund, C. Axelsson, and B. Olsson-liljequist, Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli, Scandinavian Journal of Infectious Diseases, vol.77, issue.1, pp.51-55
DOI : 10.3109/00365548.2011.592987

A. Valverde, F. Grill, T. Coque, V. Pintado, F. Baquero et al., High Rate of Intestinal Colonization with Extended-Spectrum-??-Lactamase-Producing Organisms in Household Contacts of Infected Community Patients, Journal of Clinical Microbiology, vol.46, issue.8, pp.2796-2805, 2008.
DOI : 10.1128/JCM.01008-08

D. Tande, S. Boisrame-gastrin, M. Munck, G. Hery-arnaud, S. Gouriou et al., Intrafamilial transmission of extended-spectrum-??-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children, Journal of Antimicrobial Chemotherapy, vol.65, issue.5, pp.859-65, 2010.
DOI : 10.1093/jac/dkq068

W. Lo, P. Ho, K. Chow, E. Lai, F. Yeung et al., Fecal carriage of CTXM type extended-spectrum beta-lactamase-producing organisms by children and their household contacts, Journal of Infection, vol.60, issue.4, pp.286-92, 2010.
DOI : 10.1016/j.jinf.2010.02.002

K. Laupland, D. Church, J. Vidakovich, M. Mucenski, and J. Pitout, Community-onset extended-spectrum ??-lactamase (ESBL) producing Escherichia coli: Importance of international travel, Journal of Infection, vol.57, issue.6, pp.441-449, 2008.
DOI : 10.1016/j.jinf.2008.09.034

J. Tham, I. Odenholt, M. Walder, A. Brolund, J. Ahl et al., Extended-spectrum beta-lactamaseproducing Escherichia coli in patients with travellers' diarrhoea, Scand J Infect Dis, 2010.

T. Tangden, O. Cars, A. Melhus, and E. Lowdin, Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum ??-Lactamases: a Prospective Study with Swedish Volunteers, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3564-3572, 2010.
DOI : 10.1128/AAC.00220-10

C. Ewers, M. Grobbel, I. Stamm, P. Kopp, I. Diehl et al., Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-??-lactamase-producing Escherichia coli among companion animals, Journal of Antimicrobial Chemotherapy, vol.65, issue.4, pp.651-60, 2010.
DOI : 10.1093/jac/dkq004

P. Gandolfi-decristophoris, O. Petrini, N. Ruggeri-bernardi, and E. Schelling, Extended-spectrum ??-lactamase-producing Enterobacteriaceae in healthy companion animals living in nursing homes and in the community, American Journal of Infection Control, vol.41, issue.9, pp.831-836, 2013.
DOI : 10.1016/j.ajic.2012.11.013

A. Carattoli, S. Lovari, A. Franco, G. Cordaro, D. Matteo et al., Extended-Spectrum ??-Lactamases in Escherichia coli Isolated from Dogs and Cats in Rome, Italy, from 2001 to 2003, Antimicrobial Agents and Chemotherapy, vol.49, issue.2, pp.833-838, 2001.
DOI : 10.1128/AAC.49.2.833-835.2005

J. Johnson, S. Miller, B. Johnston, C. Clabots, and C. Debroy, Sharing of Escherichia coli Sequence Type ST131 and Other Multidrug-Resistant and Urovirulent E. coli Strains among Dogs and Cats within a Household, Journal of Clinical Microbiology, vol.47, issue.11, pp.3721-3726, 2009.
DOI : 10.1128/JCM.01581-09

A. Carattoli, Animal reservoirs for extended spectrum ??-lactamase producers, Clinical Microbiology and Infection, vol.14, pp.117-140, 2008.
DOI : 10.1111/j.1469-0691.2007.01851.x

R. Warren, V. Ensor, O. Neill, P. Butler, V. Taylor et al., Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum ??-lactamases in the UK, Journal of Antimicrobial Chemotherapy, vol.61, issue.3, pp.504-512, 2008.
DOI : 10.1093/jac/dkm517

M. Dolejska, Z. Jurcickova, I. Literak, L. Pokludova, J. Bures et al., IncN plasmids carrying blaCTX-M-1 in Escherichia coli isolates on a dairy farm, Veterinary Microbiology, vol.149, issue.3-4, pp.3-4513, 2011.
DOI : 10.1016/j.vetmic.2010.11.032

V. Blanc, R. Mesa, M. Saco, S. Lavilla, G. Prats et al., ESBL-and plasmidic class C ?-lactamaseproducing E. coli strains isolated from poultry, pig and rabbit farms, Vet Microbiol, vol.118, pp.3-4299, 2006.
DOI : 10.1016/j.vetmic.2006.08.002

J. Rodriguez-bano, J. Alcalá, J. Cisneros, F. Grill, A. Oliver et al., Community Infections Caused by Extended-Spectrum ??-Lactamase???Producing Escherichia coli, Archives of Internal Medicine, vol.168, issue.17, p.1897, 2008.
DOI : 10.1001/archinte.168.17.1897

J. Rodríguez-baño, E. Picón, P. Gijón, J. Hernández, M. Ruíz et al., Risk Factors and Prognosis, Clinical Infectious Diseases, vol.50, issue.1, pp.40-48, 2010.
DOI : 10.1086/649537

C. Hsieh, Y. Shen, and K. Hwang, Clinical Implications, Risk Factors and Mortality Following Community-onset Bacteremia Caused by Extended-spectrum ??-lactamase (ESBL) and non-ESBL Producing Escherichia coli, Journal of Microbiology, Immunology and Infection, vol.43, issue.3, pp.240-248, 2010.
DOI : 10.1016/S1684-1182(10)60038-2

URL : http://doi.org/10.1016/s1684-1182(10)60038-2

J. Lee, N. Lee, H. Lee, W. Huang, K. Tsui et al., Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia and their emergence in the community, Journal of Microbiology, Immunology and Infection, vol.45, issue.2, pp.127-160, 2012.
DOI : 10.1016/j.jmii.2011.09.029

C. Arpin, C. Quentin, F. Grobost, E. Cambau, J. Robert et al., Nationwide survey of extended-spectrum ??-lactamase-producing Enterobacteriaceae in the French community setting, Journal of Antimicrobial Chemotherapy, vol.63, issue.6, pp.1205-1219, 2009.
DOI : 10.1093/jac/dkp108

URL : https://hal.archives-ouvertes.fr/hal-00426312

T. S. Réseau, MedQual : surveillance de l'évolution des résistances des souches d'escherichia coli isolées en ville. Bull Épidémiologique Santé Anim Aliment, pp.21-25, 2012.

R. Colodner, W. Rock, B. Chazan, N. Keller, N. Guy et al., Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients, European Journal of Clinical Microbiology & Infectious Diseases, vol.23, issue.3, pp.163-170, 2004.
DOI : 10.1007/s10096-003-1084-2

R. Ben-ami, J. Rodríguez-baño, H. Arslan, J. Pitout, C. Quentin et al., A Multinational Survey of Risk Factors for Infection with Extended???Spectrum ?????Lactamase???Producing Enterobacteriaceae in Nonhospitalized Patients, Clinical Infectious Diseases, vol.49, issue.5, pp.682-90, 2009.
DOI : 10.1086/604713

URL : https://hal.archives-ouvertes.fr/hal-00426315

A. Ö. Arslan, H. ?erefhano?lu, K. , Ç. ?. Erdo?an, H. Timurkaynak et al., Risk factors for extended-spectrum ?-lactamase positivity in uropathogenic Escherichia coli isolated from communityacquired urinary tract infections, Clin Microbiol Infect. Feb, vol.16, issue.2, pp.147-51, 2010.

C. Kang, Y. Wi, M. Lee, K. Ko, D. Chung et al., Epidemiology and Risk Factors of Community Onset Infections Caused by Extended-Spectrum ??-Lactamase-Producing Escherichia coli Strains, Journal of Clinical Microbiology, vol.50, issue.2, pp.312-319, 2011.
DOI : 10.1128/JCM.06002-11

L. Siedelman, S. Kline, and S. Duval, Risk factors for community- and health facility???acquired extended-spectrum ??-lactamase???producing bacterial infections in patients at the University of Minnesota Medical Center, Fairview, American Journal of Infection Control, vol.40, issue.9, pp.849-53, 2012.
DOI : 10.1016/j.ajic.2011.10.019

E. Calbo, V. Romaní, M. Xercavins, L. Gómez, C. Vidal et al., Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum ??-lactamases, Journal of Antimicrobial Chemotherapy, vol.57, issue.4, pp.780-783, 2006.
DOI : 10.1093/jac/dkl035

Y. Yang, C. Ku, J. Lin, S. Shang, C. Chiu et al., Impact of Extended-spectrum ??-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the Outcome of Community-onset Bacteremic Urinary Tract Infections, Journal of Microbiology, Immunology and Infection, vol.43, issue.3, pp.194-203, 2010.
DOI : 10.1016/S1684-1182(10)60031-X

B. Kim, J. Kim, M. Seo, S. Wie, Y. Cho et al., Clinical characteristics of communityacquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea, Infection, 2013.

D. Maraninchi, Nitrofurantoïne et risque de survenue d'effets indésirables hépatiques et pulmonaires lors de traitements prolongés [Internet] Available from: http://ansm.sante.fr/S- informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Nitrofurantoine-et-risque-desurvenue-d-effets-indesirables-hepatiques-et-pulmonaires-lors-de-traitements-prolonges-Lettre-auxprofessionnels-de-sante, 2011.

D. Maraninchi, Restriction d'utilisation de la nitrofurantoïne en raison d'un risque de survenue d'effets indésirables graves hépatiques et pulmonaires

F. Caron and T. Galperine, Infections urinaires communautaires : vers une révision des recommandations. Clermont-Ferrand, 2013.

M. Tasbakan, H. Pullukcu, O. Sipahi, T. Yamazhan, and S. Ulusoy, Nitrofurantoin in the treatment of extended-spectrum ??-lactamase-producing Escherichia coli-related lower urinary tract infection, International Journal of Antimicrobial Agents, vol.40, issue.6, pp.554-560, 2012.
DOI : 10.1016/j.ijantimicag.2012.08.003

H. Pullukcu, M. Tasbakan, O. Sipahi, T. Yamazhan, S. Aydemir et al., Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections, International Journal of Antimicrobial Agents, vol.29, issue.1, pp.62-67, 2007.
DOI : 10.1016/j.ijantimicag.2006.08.039

M. Falagas, A. Kastoris, A. Kapaskelis, and D. Karageorgopoulos, Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum ??-lactamase producing, Enterobacteriaceae infections: a systematic review, The Lancet Infectious Diseases, vol.10, issue.1, pp.43-50, 2010.
DOI : 10.1016/S1473-3099(09)70325-1

R. Chislett, G. White, T. Hills, and D. Turner, Fosfomycin susceptibility among extended-spectrum-??-lactamase-producing Escherichia coli in Nottingham, UK, Journal of Antimicrobial Chemotherapy, vol.65, issue.5, pp.1076-1083, 2010.
DOI : 10.1093/jac/dkq051

S. Auer, A. Wojna, and M. Hell, Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum-??-Lactamase-Producing Escherichia coli, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.4006-4014, 2010.
DOI : 10.1128/AAC.01760-09

J. Oteo, V. Bautista, N. Lara, O. Cuevas, M. Arroyo et al., Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum ??-lactamase (ESBL)-producing Escherichia coli, Journal of Antimicrobial Chemotherapy, vol.65, issue.11, pp.2459-63, 2010.
DOI : 10.1093/jac/dkq346

L. Bjerrum, B. Gahrn-hansen, and P. Grinsted, Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: A randomized controlled trial. Scand J Prim Health Care, pp.6-11, 2009.

S. Ferry, S. Holm, H. Stenlund, R. Lundholm, and T. Monsen, Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: The LUTIW project, Scandinavian Journal of Primary Health Care, vol.52, issue.2, pp.49-57, 2007.
DOI : 10.2165/00003495-199100424-00005

D. Fournier, C. Chirouze, J. Leroy, P. Cholley, D. Talon et al., Alternatives to carbapenems in ESBL-producing Escherichia coli infections. Médecine Mal Infect, Feb, vol.43, issue.2, pp.62-68, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00802661

S. Française-de-médecine-générale, Observatoire de la Médecine Générale [Internet] Available from

L. Actes-de-biologie-médicale, Caisse Nationale d'Assurance Maladie, p.33, 2008.

O. Gardy, Infections urinaires communautaires: les recommandations de l'AFSSAPS de 2008 sont-elles toujours adaptées à l'écologie bactérienne actuelle? [Thèse d'exercice, 2011.

C. Poly, Etude des résistances bactériennes dans les infections urinaires communautaires: quelles conséquences pour les antibiothérapies probabilistes en médecine de ville? [Thèse d'exercice, 2011.

J. Prouzergue-blancher, Analyse de la prescription antibiotique des médecins généralistes en Haute- Vienne dans le traitement des infections urinaires de l'adulte [Thèse d'exercice]. Limoges, 2011.

B. Renzis and . De, Analyse de la prise en charge de l'infection urinaire en médecine générale. A propos de 88 cas observés en médecine praticienne [Thèse d'exercice, 2003.

S. Balva, Diagnostic et traitement des infections urinaires basses de la femme: enquête auprès des médecins généralistes d'Indre-et-Loire, Ecole doctorale Santé, sciences, technologies, 1986.

G. Corvaisier, Evaluation du traitement antibiotique des cystites aiguës simples chez les médecins généralistes d'Ille-et-Vilaine [Thèse d'exercice, 2011.

K. Besancenet, Infection urinaire de l'enfant: prise en charge initiale enquête auprès des médecins généralistes du Doubs [Thèse d'exercice, 2006.

B. L. Icher, infection urinaire chez l'enfant: évolution des pratiques en médecine générale, Thèse d'exercice, 2004.

C. Colas, Le médecin généraliste de ville face aux infections urinaires basses chez la femme adulte: à propos de trois cents cas [Thèse d'exercice, 1985.

S. Aubin and H. De, Prise en charge des infections urinaires en médecine générale: état des connaissances et étude de pratique par entretiens confraternels auprès de 57 médecins généralistes de Haute-Normandie [Thèse d'exercice, 2008.

F. Hervieux, Prise en charge des infections urinaires fébriles de l'adulte en médecine générale: une enquête de pratique [Thèse d'exercice], 2009.

. Société-de-pathologie-infectieuse-de-langue-française, Deuxième conférence de consensus en thérapeutique anti-infectieuse: antibiothérapie des infections urinaires -16 Novembre, Médecine Mal Infect. Feb, vol.21, issue.2, pp.51-55, 1990.

. Commission-de-la-transparence, SELEXID 200 mg, comprimé pelliculé [Internet] Haute Autorité de Santé Available from, 2013.

S. Molliex, S. Pierre, C. Bléry, E. Marret, and H. Beloeil, Examens préinterventionnels systématiques. Annales francaises d'anesthesie et de reanimation, 2012.

I. Vidal, Issy-les-Moulineaux: Vidal, 2013.

I. Monographie-de-produit, Available from: http://www.merck.ca, Merck Canada Inc, 1975.

A. Zucchoni, V. Mondain, C. Mauruéjouls, F. Saintpère, N. Degand et al., Le kit BLSE, un outil d'aide à la prise en charge des infections urinaires communautaires à E. coli porteur de Béta- Lactamase à Spectre Elargi (BLSE) [Internet]. Clermont-Ferrand; 2013 Available from

C. Miclot, Etude des pratiques des médecins généralistes dans la prise en charge des infections urinaires à entérobactéries sécrétrices de bêta-lactamase à spectre étendu [Thèse d'exercice], 2013.
DOI : 10.1016/s0399-077x(14)70249-5